Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of liver disease in the pediatric patient.

Literature DB >> 10551891

Evaluation of liver disease in the pediatric patient.

I D D'Agata¹, W F Balistreri.

Abstract

Entities: Disease Species

Mesh：

Substances：
Bilirubin

Year: 1999 PMID： 10551891

Source DB: PubMed Journal: Pediatr Rev ISSN： 0191-9601

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients.

Authors: Michele Luglio; Uenis Tannuri; Werther Brunow de Carvalho; Karina Lucio de Medeiros Bastos; Isadora Souza Rodriguez; Cintia Johnston; Artur Figueiredo Delgado
Journal: Clinics (Sao Paulo) Date: 2020-11-11 Impact factor: 2.365

2. The significance of isolated elevation of serum aminotransferases in infants and young children.

Authors: Nina Bugeac; Avi Pacht; Hanna Mandel; Theodore Iancu; Ada Tamir; Isaac Srugo; Ron Shaoul
Journal: Arch Dis Child Date: 2007-07-25 Impact factor: 3.791

3. Isolated persistent elevation of alanine transaminase for early diagnosis of pre-symptomatic Wilson's disease in Chinese children.

Authors: Joannie Hui; Yuet-Ping Yuen; Chung-Mo Chow; Josephine Chong; Grace Chiang; Chi Keung Cheung; Eric L K Law; Chloe Miu Mak; Ching-Wan Lam; Patrick M P Yuen; Nelson L S Tang
Journal: World J Pediatr Date: 2013-10-21 Impact factor: 2.764

4. Persistent alanine aminotransferase elevations in children with parenteral nutrition-associated liver disease.

Authors: Chi-Fu Jeffrey Yang; Michele Lee; Clarissa Valim; Melissa A Hull; Jing Zhou; Brian A Jones; Kathy Gura; Sharon Collier; Clifford Lo; Christopher Duggan; Tom Jaksic
Journal: J Pediatr Surg Date: 2009-06 Impact factor: 2.545

5. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.

Authors: J B Schwimmer; K P Newton; H I Awai; L J Choi; M A Garcia; L L Ellis; K Vanderwall; J Fontanesi
Journal: Aliment Pharmacol Ther Date: 2013-10-01 Impact factor: 8.171

6. Biological Safety and Biodistribution of Chitosan Nanoparticles.

Authors: Dmitry Sonin; Evgeniia Pochkaeva; Sergei Zhuravskii; Viktor Postnov; Dmitry Korolev; Lyubov Vasina; Daria Kostina; Daria Mukhametdinova; Irina Zelinskaya; Yury Skorik; Elena Naumysheva; Anna Malashicheva; Pavel Somov; Maria Istomina; Natalia Rubanova; Ilia Aleksandrov; Marina Vasyutina; Michael Galagudza
Journal: Nanomaterials (Basel) Date: 2020-04-23 Impact factor: 5.076

Evaluation of liver disease in the pediatric patient.

Review 1. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients.

2. The significance of isolated elevation of serum aminotransferases in infants and young children.

3. Isolated persistent elevation of alanine transaminase for early diagnosis of pre-symptomatic Wilson's disease in Chinese children.

4. Persistent alanine aminotransferase elevations in children with parenteral nutrition-associated liver disease.

5. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.

6. Biological Safety and Biodistribution of Chitosan Nanoparticles.

Review 7. What is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?

Review 8. Pediatric Fibrinogen PART II-Overview of Indications for Fibrinogen Use in Critically Ill Children.

9. Population Pharmacokinetics of IV Phenobarbital in Neonates After Congenital Heart Surgery.

10. Perihepatic lymphadenopathy in children with chronic viral hepatitis.